Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones. / Faurholt-Jepsen, Maria; Ritz, Christian; Frost, Mads; Mikkelsen, Rie Lambæk; Margrethe Christensen, Ellen; Bardram, Jakob; Vinberg, Maj; Kessing, Lars Vedel.

In: Journal of Affective Disorders, Vol. 186, 2015, p. 342-349.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Faurholt-Jepsen, M, Ritz, C, Frost, M, Mikkelsen, RL, Margrethe Christensen, E, Bardram, J, Vinberg, M & Kessing, LV 2015, 'Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones', Journal of Affective Disorders, vol. 186, pp. 342-349. https://doi.org/10.1016/j.jad.2015.06.026

APA

Faurholt-Jepsen, M., Ritz, C., Frost, M., Mikkelsen, R. L., Margrethe Christensen, E., Bardram, J., Vinberg, M., & Kessing, L. V. (2015). Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones. Journal of Affective Disorders, 186, 342-349. https://doi.org/10.1016/j.jad.2015.06.026

Vancouver

Faurholt-Jepsen M, Ritz C, Frost M, Mikkelsen RL, Margrethe Christensen E, Bardram J et al. Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones. Journal of Affective Disorders. 2015;186:342-349. https://doi.org/10.1016/j.jad.2015.06.026

Author

Faurholt-Jepsen, Maria ; Ritz, Christian ; Frost, Mads ; Mikkelsen, Rie Lambæk ; Margrethe Christensen, Ellen ; Bardram, Jakob ; Vinberg, Maj ; Kessing, Lars Vedel. / Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones. In: Journal of Affective Disorders. 2015 ; Vol. 186. pp. 342-349.

Bibtex

@article{1788f3494c6d47ce94c50c7942820900,
title = "Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones",
abstract = "BACKGROUND: A substantial proportion of patients with bipolar disorder remain symptomatic during inter-episode periods, and mood instability is associated with high risk of relapse and hospitalization. Few studies have investigated long-term daily illness activity and none has compared bipolar type I and II using daily data. The objectives were to investigate differences in daily illness activity between bipolar disorder type I and II.METHODS: A smartphone-based system for self-monitoring was developed. A total of 33 patients treated in a mood clinic used the system for daily self-monitoring during a median period of 310 days [IQR 189; 437]. Data presented summarize over 8500 observations.RESULTS: Patients with bipolar disorder type II (n=20), compared to patients with bipolar disorder type I (n=13), experienced a significant lower mean level of mood on a scale from -3; +3 (-0.54 (95% CI: -0.74; -0.35) versus -0.19 (95% CI: -0.35; -0.02), p=0.02), less time euthymic (51.0% (95% CI: 36.4; 65.7) versus 74.5% (95% CI: 62.4; 86.7), p=0.03) and a higher proportion of time with depressive symptoms (45.1% (95% CI: 30.6; 59.5) versus 18.8% (95% CI: 6.9; 30.7), p=0.01). The proportion of time spent with (hypo)manic symptoms did not differ (2.7% (95% CI: 0.1; 5.5) versus 5.5% (95% CI: 3.1; 7.8), p=0.17).LIMITATIONS: Patients received different types, doses and combinations of psychopharmacological treatment.CONCLUSION: Euthymia was obtained for a substantial proportion of time in patients with bipolar disorder type I, but despite on-going treatment only for half of the time for patients with bipolar disorder type II. This emphasizes the need for improving treatment strategies for bipolar disorder type II.",
author = "Maria Faurholt-Jepsen and Christian Ritz and Mads Frost and Mikkelsen, {Rie Lamb{\ae}k} and {Margrethe Christensen}, Ellen and Jakob Bardram and Maj Vinberg and Kessing, {Lars Vedel}",
note = "CURIS 2015 NEXS 331",
year = "2015",
doi = "10.1016/j.jad.2015.06.026",
language = "English",
volume = "186",
pages = "342--349",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones

AU - Faurholt-Jepsen, Maria

AU - Ritz, Christian

AU - Frost, Mads

AU - Mikkelsen, Rie Lambæk

AU - Margrethe Christensen, Ellen

AU - Bardram, Jakob

AU - Vinberg, Maj

AU - Kessing, Lars Vedel

N1 - CURIS 2015 NEXS 331

PY - 2015

Y1 - 2015

N2 - BACKGROUND: A substantial proportion of patients with bipolar disorder remain symptomatic during inter-episode periods, and mood instability is associated with high risk of relapse and hospitalization. Few studies have investigated long-term daily illness activity and none has compared bipolar type I and II using daily data. The objectives were to investigate differences in daily illness activity between bipolar disorder type I and II.METHODS: A smartphone-based system for self-monitoring was developed. A total of 33 patients treated in a mood clinic used the system for daily self-monitoring during a median period of 310 days [IQR 189; 437]. Data presented summarize over 8500 observations.RESULTS: Patients with bipolar disorder type II (n=20), compared to patients with bipolar disorder type I (n=13), experienced a significant lower mean level of mood on a scale from -3; +3 (-0.54 (95% CI: -0.74; -0.35) versus -0.19 (95% CI: -0.35; -0.02), p=0.02), less time euthymic (51.0% (95% CI: 36.4; 65.7) versus 74.5% (95% CI: 62.4; 86.7), p=0.03) and a higher proportion of time with depressive symptoms (45.1% (95% CI: 30.6; 59.5) versus 18.8% (95% CI: 6.9; 30.7), p=0.01). The proportion of time spent with (hypo)manic symptoms did not differ (2.7% (95% CI: 0.1; 5.5) versus 5.5% (95% CI: 3.1; 7.8), p=0.17).LIMITATIONS: Patients received different types, doses and combinations of psychopharmacological treatment.CONCLUSION: Euthymia was obtained for a substantial proportion of time in patients with bipolar disorder type I, but despite on-going treatment only for half of the time for patients with bipolar disorder type II. This emphasizes the need for improving treatment strategies for bipolar disorder type II.

AB - BACKGROUND: A substantial proportion of patients with bipolar disorder remain symptomatic during inter-episode periods, and mood instability is associated with high risk of relapse and hospitalization. Few studies have investigated long-term daily illness activity and none has compared bipolar type I and II using daily data. The objectives were to investigate differences in daily illness activity between bipolar disorder type I and II.METHODS: A smartphone-based system for self-monitoring was developed. A total of 33 patients treated in a mood clinic used the system for daily self-monitoring during a median period of 310 days [IQR 189; 437]. Data presented summarize over 8500 observations.RESULTS: Patients with bipolar disorder type II (n=20), compared to patients with bipolar disorder type I (n=13), experienced a significant lower mean level of mood on a scale from -3; +3 (-0.54 (95% CI: -0.74; -0.35) versus -0.19 (95% CI: -0.35; -0.02), p=0.02), less time euthymic (51.0% (95% CI: 36.4; 65.7) versus 74.5% (95% CI: 62.4; 86.7), p=0.03) and a higher proportion of time with depressive symptoms (45.1% (95% CI: 30.6; 59.5) versus 18.8% (95% CI: 6.9; 30.7), p=0.01). The proportion of time spent with (hypo)manic symptoms did not differ (2.7% (95% CI: 0.1; 5.5) versus 5.5% (95% CI: 3.1; 7.8), p=0.17).LIMITATIONS: Patients received different types, doses and combinations of psychopharmacological treatment.CONCLUSION: Euthymia was obtained for a substantial proportion of time in patients with bipolar disorder type I, but despite on-going treatment only for half of the time for patients with bipolar disorder type II. This emphasizes the need for improving treatment strategies for bipolar disorder type II.

U2 - 10.1016/j.jad.2015.06.026

DO - 10.1016/j.jad.2015.06.026

M3 - Journal article

C2 - 26277270

VL - 186

SP - 342

EP - 349

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -

ID: 143888013